Ashley Grossman was awarded a degree in Psychology and Social Anthropology from the University of London, followed by a First Class degree in Anatomy and University Gold Medal from University College Hospital Medical School. Following 'house jobs' at many London hospitals, he joined the Department of Endocrinology at St Bartholomew's Hospital eventually becoming Professor of Neuroendocrinology at Barts and the London School of Medicine in 1993, a position he still holds.
He moved to the Oxford Centre for Diabetes Endocrinology and Metabolism in 2011 where he was appointed Professor of Endocrinology at the University of Oxford and fellow of Green-Templeton College in 2012. Professor Grossman is also currently Consultant in neuroendocrine tumours at the Royal Free Hospital, London, in the ENETS Centre of Excellence.
He was awarded MRCP in 1978, FRCP in 1990, MD in 1992 and Fellow of the Academy of Medical Sciences in 1999. He has published some 480 peer-reviewed papers and 350 chapters and reviews, originally in the field of hypothalamo-pituitary regulation, but more recently in hypothalamic and pituitary tumours, and endocrine oncology. He was awarded the Clinical Endocrinology Trust prize lecture in 2004, the European Society for Endocrinology Geoffrey Harris Prize in 2014, and the Iain MacIntyre prize lecture at Barts and the London in 2017.
Professor Grossman is past-president of the European Neuroendocrine Association, the Society for Endocrinology and the Pituitary Society, and past-chairman of the UK and Ireland Neuroendocrine Tumour Society.
Professor Grossman's has disclosed that he receives lecture fees and advisory board fees from Novartis, Ipsen and HRA Pharma.